Health TrialsbyHealthPanel

Internet-based Affect Focused Psychodynamic Therapy for Neuroticism: a Randomized Controlled Trial

ConditionTrait Neuroticism
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLinkoeping University

About this trial

The purpose of the study is to investigate if internet delivered affect-focused psychodynamic therapy (IPDT) leads to lowered levels of trait neuroticism compared to a wait-list control condition. The target group is adults (18+) who experience mild to moderate symptoms of anxiety and/or depression. The IPDT treatment consists of 8 modules that the participants will work with for 9 weeks, with therapist support. Participants will be recruited in Sweden with nationwide recruitment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Score 5 points or more on either the PHQ-9 or GAD-7

18 years or older

Ability to speak, read and write in Swedish

Have access to the internet and a smartphone, computer or other device

Disqualifiers

Severe psychiatric or somatic illness that makes participation difficult or impossible

Ongoing addiction

Acute suicidality

Other ongoing psychological treatment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Internet-based psychodynamic therapy (IPDT)

    Behavioral

    The intervention is 9 week long with weekly modules that the participants work with while receiving weekly support from an assigned therapist.

Treatment groups

108 Participants
are divided into 2 treatment groups
Group A: Internet-based psychodynamic therapyExperimental treatment 1 intervention
Group B: Wait-list control conditionNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Neuroticism scale of the Maples et al (2014) IPIP NEO PI 120 Item representation

Measure of trait neuroticism. Consists of 24 items. Each item is scored from 0-4 with a total range of 0-96. A higher score reflects a higher level of trait neuroticism.

Time frame
Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.

Secondary outcomes

1

Eysenck Personality Questionnaire Revised - Shortform (EPQR-S)

12-item measure of trait neuroticism. Each item is score yes or no. Range 0-12 with a higher score indicating higher levels of neuroticism.

Time frame
Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.
2

Patient Health Questionnaire-9

Measure depressive symptoms. Consist of nine items, scored from 0-3. A higher score indicates more depressive symptoms.

Time frame
Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.
3

Generalized Anxiety Disorder-7

Measures symptoms of anxiety. 7 items scored from 0-3, with a higher score indicating more anxiety symptoms.

Time frame
Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.
4

Brunnsviken Brief Quality of life scale

Measures quality of life. 12 items scored from 0-4. A higher score indicates higher quality of life.

Time frame
Change between baseline, end of treatment after nine weeks and follow-up at 12 months after treatment termination.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Linkoeping University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: